Publication:
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.

dc.contributor.authorGarrido, P
dc.contributor.authorAldaz, A
dc.contributor.authorVera, R
dc.contributor.authorCalleja, M A
dc.contributor.authorde Álava, E
dc.contributor.authorMartín, M
dc.contributor.authorMatías-Guiu, X
dc.contributor.authorPalacios, J
dc.date.accessioned2023-01-25T09:51:34Z
dc.date.available2023-01-25T09:51:34Z
dc.date.issued2017-08-31
dc.description.abstractPrecision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational, and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals, and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology, Pathology, and Hospital Pharmacy, we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.
dc.identifier.doi10.1007/s12094-017-1740-0
dc.identifier.essn1699-3055
dc.identifier.pmcPMC5978896
dc.identifier.pmid28861725
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978896/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007%2Fs12094-017-1740-0.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11550
dc.issue.number4
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number443-447
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectConsensus
dc.subjectOncology
dc.subjectPrecision medicine
dc.subject.meshHealth Policy
dc.subject.meshHumans
dc.subject.meshMedical Oncology
dc.subject.meshNeoplasms
dc.subject.meshPrecision Medicine
dc.subject.meshSpain
dc.titleProposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5978896.pdf
Size:
345.99 KB
Format:
Adobe Portable Document Format